Gianluca Torregrossa, MD
Cardiac Surgery
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
MaleAbout Gianluca Torregrossa
Biography
Gianluca Torregrossa, MD, is the Director of Robotic Coronary Artery Surgery in the Department of Thoracic and Cardiovascular Surgery in the Heart, Vascular & Thoracic Institute. He sees patients at Main Campus.
Specialty interests: Coronary Artery Bypass Grafting (CABG), Robotic Coronary Surgery, Totally Endoscopic Coronary Artery Bypass (TECAB), Multi-Arterial Coronary Revascularization, Hybrid Coronary Revascularization, Off-Pump and Anaortic Coronary Surgery, Minimally Invasive Cardiac Surgery, Robotic Mitral Valve Surgery, Valve Repair and Reconstruction, Surgical Innovation and Advanced Cardiac Technologies
Experience and Outcomes: Cleveland Clinic performs more than 5,000 heart surgeries each year. All Cleveland Clinic cardiac surgeons complete between 300-400 cardiac cases per year. As one of the nation's highest-volume cardiac surgical centers, Cleveland Clinic treats highly complex and critically ill patients, performing procedures that only a handful of surgeons across the country can do. View success rates and outcomes HERE
Learn more about the Cardiovascular Surgery Department HERE.
Publications and Speaking: Dr. Torregrossa has authored more than 160 peer-reviewed scientific publications, book chapters, and invited reviews. He is a frequently invited speaker at national and international cardiovascular meetings.
About Dr. Torregrossa: “I believe my greatest strength as a heart surgeon is my ability to offer patients a full range of treatment options—from traditional open-heart surgery to minimally invasive and robotic approaches—while always focusing on safety, quality, and long-term outcomes.”
“I chose cardiac surgery because it combines innovation, precision, and the opportunity to make a meaningful difference in people's lives. Every patient is unique, and I am committed to developing a personalized treatment plan that reflects their goals, anatomy, and overall health. My philosophy is simple: provide the best operation for each individual patient while treating them with the same care and respect I would offer a member of my own family.”
Leisure Activities: Outside of medicine, Dr. Torregrossa enjoys spending time with his wife and daughter, traveling, aviation, music, and restoring classic automobiles. He is also passionate about adventure travel and exploring different cultures around the world.
Videos: To learn more about Dr. Torregrossa and his expertise, watch his videos HERE
Education & Board Certifications
Education
- Fellowship: Mount Sinai Hospital , 2016
- Fellowship: Mount Sinai Hospital , 2015
- Residency: Universita Degli Studi Di Padova - Department of Cardiac Surgery , 2012
- Medical Education: Universita Di Padova Faculty of Medicine, 2006
Professional Highlights
- Director, Robotic Coronary Artery Surgery Program, Cleveland Clinic
- Internationally recognized specialist in robotic and minimally invasive coronary artery bypass surgery
- Leader in the development and adoption of totally endoscopic coronary artery bypass (TECAB)
- Former Director of the Robotic Coronary Surgery Program at Lankenau Heart Institute
- Performed more than 250 major cardiac operations annually, including one of the largest robotic coronary surgery experiences in North America
- Author of more than 160 peer-reviewed scientific publications, book chapters, and invited reviews
- Frequent invited speaker at national and international cardiovascular meetings
- Program Director and Chair of the International Coronary Congress
- Course Director for the Society of Thoracic Surgeons Robotic Cardiac Surgery Workshop
Awards
- Distinguished Medal of Honor, University of Padua, Italy
- Rotary International Travel Fellowship Award
- Cox Maze Fellowship Award, American Association for Thoracic Surgery
- Premio Maria Paola Belloni for Excellence in Robotic Cardiac Surgery
- Paul Harris Fellow, Rotary International
Professional Memberships
- Society of Thoracic Surgeons
- European Association for Cardio-Thoracic Surgery
- International Society for Coronary Artery Surgery
- Society of Robotic Surgery
- Member, EACTS Innovation Committee
- Member, STS Workforce on Standalone Meetings
- Member, STS Workforce on E-Learning and Educational Innovation
Research & Publications
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-07-14, Dr. Torregrossa has reported the financial relationships with the companies listed below.
Donation of Financial Interest. Dr. Torregrossa has consulted for, received compensation for serving as a fiduciary from, or received royalties from the following companies but instructed them to donate all compensation to not-for-profit causes or to the Cleveland Clinic to support research and education:
- AtriCure, Inc.
Consulting and/or Speaking. Dr. Torregrossa receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Medtronic ATS Medical, Inc.
- Peters Surgical
- Intuitive Surgical, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.